SCHEMBL623644

SCHEMBL623644

COc1ccccc1-c1ccc(C=C2SC(=S)NC2=O)o1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 7/20 0.81
▸ INSR P06213 2/20 0.69
▸ IGF1R P08069 2/20 0.69
▸ PTP4A3 O75365 1/20 0.65
▸ NAT1 P18440 1/20 0.62
▸ PIM1 P11309 1/20 0.60
▸ GSK3B P49841 2/20 0.59
▸ HSPD1 P10809 1/20 0.57
▸ HSPE1 P61604 1/20 0.57
▸ PDE4B Q07343 2/20 0.56
▸ KDM4E B2RXH2 2/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ RECQL P46063 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ PIK3CA P42336 1/20 0.55
▸ PIK3CB P42338 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.54
▸ GLA P06280 1/20 0.54
▸ GAA P10253 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623642 1.00 PIK3CG (0.81) PIK3CGINSRIGF1RPTP4A3NAT1
SCHEMBL623643 1.00 PIK3CG (0.81) PIK3CGINSRIGF1RPTP4A3NAT1
SCHEMBL622537 0.87 PIK3CG (0.79) PIK3CGINSRIGF1RGSK3BKDM4E
SCHEMBL622538 0.87 PIK3CG (0.79) PIK3CGINSRIGF1RGSK3BKDM4E
SCHEMBL623775 0.82 IGF1R (1.00) PIK3CGINSRIGF1RPTP4A3PIM1
SCHEMBL6090645 0.82 IGF1R (0.74) PIK3CGINSRIGF1RPTP4A3PIM1
SCHEMBL6090652 0.82 IGF1R (0.74) PIK3CGINSRIGF1RPTP4A3PIM1
SCHEMBL623774 0.82 IGF1R (1.00) PIK3CGINSRIGF1RPTP4A3PIM1
SCHEMBL622799 0.82 PIK3CG (0.80) PIK3CGINSRIGF1RPTP4A3PIM1
SCHEMBL622800 0.82 PIK3CG (0.80) PIK3CGINSRIGF1RPTP4A3PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255088-B2 Premature-termination-codons readthrough compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-02-09 — — US disclosed
US-20130274283-A1 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-10-17 — — US disclosed
WO-2012021707-A2 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274283-A1 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS UPF1, NUDT21, RNGTT PIK3CG 3728/4885INSR 4125/4885IGF1R 4789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback